Back
Apellis Pharmaceuticals, Inc. Vs. Argan, Inc. Industry Stock Comparison
Buy
53
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$23.86
Seasonality Move:
12.69%
Buy
57
AGX
Argan, Inc.
Last Price:
$321.92
Seasonality Move:
7.33%
Buy
53
Apellis Pharmaceuticals, Inc. (APLS)
is a Buy
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $23.63. The Score for APLS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Argan, Inc. (AGX)
is a Buy
Is Argan, Inc. a Buy, Sell or Hold?
-
The current Argan, Inc. [AGX] share price is $313.70. The Score for AGX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
AGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $23.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
AGX Stock Price Chart
What is Argan, Inc.'s stock price today?
-
The Argan, Inc. share price today is $313.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 61.53 | Buy |
| Chaikin Money Flow: | 2449128 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.42 - 21.5) | Buy |
| Bollinger Bands (100): | (20.46 - 26.84) | Sell |
AGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 11.17 | Buy |
| Relative Strength Index (14 RSI): | 43.09 | Sell |
| Chaikin Money Flow: | 1140044 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (319.66 - 368.7) | Sell |
| Bollinger Bands (100): | (221.89 - 321.81) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.6 | Buy |
| 20-day SMA: | 20.47 | Buy |
| 50-day SMA: | 22.93 | Buy |
| 200-day SMA: | 21.99 | Buy |
| 8-day EMA: | 21.71 | Buy |
| 20-day EMA: | 21.42 | Buy |
| 50-day EMA: | 22.33 | Buy |
| 200-day EMA: | 24.23 | Sell |
AGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 361.44 | Sell |
| 20-day SMA: | 352.42 | Sell |
| 50-day SMA: | 312.87 | Buy |
| 200-day SMA: | 220.14 | Buy |
| 8-day EMA: | 350.34 | Sell |
| 20-day EMA: | 346.11 | Sell |
| 50-day EMA: | 317.4 | Sell |
| 200-day EMA: | 237.51 | Buy |
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.
Argan, Inc. Earnings Growth & AGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.33 per share, an increase this year of $2.73 per share, and an increase next year of $3.21 per share.
Apellis Pharmaceuticals, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Argan, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||